MedTrace Logo

Characterization of Anti-HLA Alloimmunization After Pulmonary Valve Homograft Insertion

NCT06113224 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2023-11-02

No results posted yet for this study

Summary

This is a prospective, monocentric, observational cohort study whose main objective is to describe the number and rate of patients who developed DSAs (Donor Specific Antibody) at 6 months post-surgery with implantation of a cryopreserved lung homograft.

Conditions

  • Lung Graft Dysfunction

Interventions

PROCEDURE

Blood collection T0

2 blood samples will be taken in addition to the pre-operative check-up.

PROCEDURE

Blood collection 6 months

1 blood sample will be taken 6 months after surgery.

Sponsors & Collaborators

  • Assistance Publique Hopitaux De Marseille

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-31
Primary Completion
2026-06-30
Completion
2027-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06113224 on ClinicalTrials.gov